# EDGAR Filing Document

**Accession Number:** 0001141103
**File Stem:** 0001628280-26-025765
**Filing Date:** 2026-4
**Character Count:** 8201
**Document Hash:** edd3d54913ea23633a661bc3f77a6335
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-025765.hdr.sgml**: 20260417

**ACCESSION NUMBER**: 0001628280-26-025765

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260417

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260417

**DATE AS OF CHANGE**: 20260417

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CROSS COUNTRY HEALTHCARE INC
- **CENTRAL INDEX KEY:** 0001141103
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 134066229
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-33169
- **FILM NUMBER:** 26871889

**BUSINESS ADDRESS:**
- **STREET 1:** 5201 CONGRESS AVENUE, SUITE 160
- **CITY:** BOCA RATON
- **STATE:** FL
- **BUSINESS PHONE:** 8003472264

**MAIL ADDRESS:**
- **STREET 1:** 5201 CONGRESS AVENUE, SUITE 160
- **CITY:** BOCA RATON
- **STATE:** FL

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CROSS COUNTRY INC
- **DATE OF NAME CHANGE:** 20010521

?xml version='1.0' encoding='ASCII'? ccrn-20260417

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported) April 17, 2026

![Filing - Cross Country full logo_2-2024.jpg](ccrn-20260417_g1.jpg)

**Cross Country Healthcare, Inc.** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **0-33169** | **13-4066229** |
| (State or Other Jurisdiction<br>of Incorporation) | (Commission<br>File Number) | (I.R.S. Employer<br>Identification No.) |

---

**5201 Congress Avenue, Suite 160, Boca Raton, FL 33487**

(Address of Principal Executive Office) (Zip Code)

**(561) 998-2232**

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name or former address, if changed since last report)

**Securities registered pursuant to Section 12(b) of the Act:**

**&nbsp;&nbsp;&nbsp;&nbsp;Title of each class &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trading Symbol &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name of each exchange on which registered**

Common stock, par value $0.0001 per share &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CCRN&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Nasdaq Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

------

**Item 7.01&nbsp;&nbsp;&nbsp;&nbsp;Regulation FD Disclosure.**

On April 17, 2026, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of such section. Furthermore, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

**Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits**

(d) Exhibits

---

| | |
|:---|:---|
| Exhibit | Description |
| <u>[99.1](ccrn20260417-earningscalle.htm)</u> | <u>[Press Release issued by the Company on April 17, 2026](ccrn20260417-earningscalle.htm)</u> |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;104.1&nbsp;&nbsp;&nbsp;&nbsp; Cover Page Interactive Data File (embedded within the Inline XBRL document)

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | **CROSS COUNTRY HEALTHCARE, INC.** | **CROSS COUNTRY HEALTHCARE, INC.** |
| Dated: | April 17, 2026 | By: | /s/ William J. Burns |
|  |  |  | Name: William J. Burns |
|  |  |  | Title: Executive Vice President & Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1** 

**Cross Country Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026**

BOCA RATON, Fla.—April 17, 2026—Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026 at 5:00 P.M. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Thursday, May 7, 2026.

This call will be webcast live and can be accessed at the Company's website at <u>ir.crosscountry.com</u> or by dialing 800-369-2163 from anywhere in the U.S. or by dialing 773-756-4715 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from May 7<sup>th</sup> through May 21<sup>st</sup> on the Company's website and a replay of the conference call will be available by telephone by calling 866-360-7724 from anywhere in the U.S. or 203-369-0176 from non-U.S. locations – Passcode: 9827.

**About Cross Country Healthcare** 

Cross Country Healthcare, Inc. (Nasdaq: CCRN), is a technology-driven healthcare workforce solutions company, delivering an AI-powered digital platform and advisory services backed by nearly 40 years of healthcare labor expertise to help health systems optimize and sustain their entire labor ecosystem.

Through its proprietary Intellify<sup>®</sup> platform, Cross Country helps healthcare organizations gain control across their labor ecosystem—improving workforce visibility, optimizing internal resources, and reducing complexity. Intellify<sup>®</sup> is a cloud-based workforce management and vendor management system that supports per diem staffing, internal float pools, and data-driven workforce decisions through real-time analytics and AI-driven insights. The platform streamlines reporting and operational workflows to help health systems reduce labor costs, improve flexibility, and maintain high-quality outcomes.

Copies of this and other news releases, as well as additional information about the Company, can be accessed online at <u>ir.crosscountry.com</u>. Stockholders and prospective investors can also register to automatically receive the Company's press releases, filings with the Securities and Exchange Commission, and other notices by e-mail.

CONTACT:

Cross Country Healthcare, Inc. <br>Josh Vogel, 561-237-8310<br>Vice President, Investor Relations<br>**<u>jvogel@crosscountry.com</u>**

Source: Cross Country Healthcare, Inc.

<br>